Disposition and metabolism of F6-1α,25(OH)2 vitamin D3 and 1α,25(OH)2 vitamin D3 in the parathyroid glands of rats dosed with tritium-labeled compounds

Drug Metabolism and Disposition

Volumn 31, Issue 8, 2003, Pages 973-978

  Komuro, Setsuko ^a   Sato, Masayuki ^a,b   Kanamaru, Hiroshi ^a  

^a SUMITOMO CHEMICAL CO LTD   (Japan)

^b ARCO Chemical (Deutschland) GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

26,26,26,27,27,27 HEXAFLUORO 1,23,25 TRIHYDROXYCOLECALCIFEROL; CALCITRIOL; FLUORINE DERIVATIVE; ST 233; TRITIUM; TRQ 6721; TRQ 7362; TRQ 8742; 26,26,26,27,27,27 HEXAFLUORO 1,23,25 TRIHYDROXYVITAMIN D3; 26,26,26,27,27,27-HEXAFLUORO-1,23,25-TRIHYDROXYVITAMIN D3; 26,26,26,27,27,27-HEXAFLUORO-1,25-DIHYDROXYVITAMIN D3; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FALECALCITRIOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DISPOSITION; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENCY; KIDNEY; MALE; NONHUMAN; PARATHYROID GLAND; PRIORITY JOURNAL; RADIOACTIVITY; SMALL INTESTINE; ANIMAL; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; HUMERUS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; RAT; TIME; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

ANIMALS; CALCITRIOL; HUMERUS; INJECTIONS, INTRAVENOUS; INTESTINE, SMALL; KIDNEY; MALE; PARATHYROID GLANDS; RATS; RATS, WISTAR; TIME FACTORS; TISSUE DISTRIBUTION; TRITIUM;

EID: 0042526148     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.8.973     Document Type: Article

References (33)

1. Akiba T, Marumo F, Owada A, Kurihara S, Inoue A, Chida Y, Ando R, Shinoda T, Ishida Y, and Ohashi Y (1998) Controlled trial of falecalcitoriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 32:238-246.
2. Brown AJ, Berkoben M, Ritter C, Kubodera N, Nishii Y, and Slatopolsky E (1992a) Metabolism of 22-oxacalcitriol by a vitamin D-inducible pathway in cultured parathyroid cells. Biochem Biophys Res Commun 189:759-764.
3. 3 in cultured bovine parathyroid cells. Endocrinology 30:276-281.
4. 3, is a potent suppressor of parathyroid hormone secretion. J Cell Biochem 73:106-113.
5. 3 in the regulation of vitamin D receptor expression by rat parathyroid gland. Endocrinology 136:1419-1425.
6. 3 suppress parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology 117:2114-2119.
7. Chertow BS, Baylink DJ, Wergdeal JE, Sherrard DJ, and Norman QW (1975) Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Investig 56:668-678.
8. 3. Proc Natl Acad Sci USA 89:8097-8101.
9. Hayashi H, Akiyoshi-Shibata M, Sakaki T, and Yabusaki Y (1998) Rat CYP24 catalyzes 23S-hydroxylation of 26,26,26,27,27,27-hexafluorocalcitriol in vitro. Xenobiotica 28:457-463.
10. Hellman P, Liu W, Torma H, and Akerstrom G (1999) Vitamin D and retinoids in parathyroid glands. Int J Mol Med 3:355-361.
11. 3-26,23-lactone biosynthesis. Biochemistry 23:3973-3979.
12. 3 on bovine parathyroid cells. J Steroid Biochem Mol Biol 70:243-248.
13. 3. Biochem Pharmacol 45: 2331-2336.
14. Inoue S and Fujimi S (1998) Efficacy and safety of long term oral falecalcitriol treatment in patients with renal osteodystrophy. J Bone Miner Metab 16:44-54.
15. Jones G, Ramshaw H, Zhang A, Cook R, Byford V, White J, and Petkovich M (1999) Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1 alpha and CYP24) in human nonsmall cell lung carcinomas. Endocrinology 140:3303-3310.
16. Katsumata T, Ishibashi E, Tanaka T, and Nakatsuka M (1996) Biological activity of falecalcitriol. Kiso to Rinsho 30:2955-2962.
17. 3 on human bone-derived cells. Endocrinology 128:81-86.
18. 3H-falecalcitriol in rats. Xenobio Metab Dispos 11:518-529.
19. 3 in the bones of rats dosed with tritium labeled compounds. Steroids 63:505-510.
20. 3H-falecalcitriol in rats. Xenobio Metab Dispos 11:505-517.
21. 3H-falecalcitriol in dogs-. Kiso to Rinsho 30:2915-2932.
22. 3-24-hydroxylase (CYP24) responsible for 23S-hydroxylation in target tissues causes a drop in serum levels. Xenobiotica 29:603-613.
23. Mayer GP and Hurst JG (1978) Sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves. Endocrinology 102:1036-1042.
24. Morii H, Ogura Y, Koshikawa S, Mimura N, Suzuki M, Kurokawa K, Marumo F, Kawaguchi Y, Maeda K, Nishizawa Y, et al. (1998) Efficacy and safety of oral farecalcitriol in reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism. J Bone Miner Metab 16:34-43.
25. Nakatsuka K, Imanishi Y, Morishima Y, Sekiya K, Sasao K, Miki T, Nishizawa Y, Katsumata T, Nagata A. Murakawa S, and Morii H (1992) Biological potency of a fluorinated vitamin D analogue in hyperparathyroidism. Bone Miner 16:73-81.
26. 3 in the parathyroid in vivo. J Clin Investig 86:1968-1975.
27. Russell J, Lettiere D, and Sherwood LM (1986) Direct regulation by calcium of cytoplasmic messenger ribonucleic acid coding for preproparathyroid hormone in isolated bovine parathyroid cells. J Clin Investig 72:1851-1855.
28. 3 by CYP24: species-based difference between humans and rats. Biochem Pharmacol 65:1957-1965.
29. 3-alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 87:2967-2972.
30. Silver J, Naveh-Many T, Mayer H, Schmeizer HJ, and Popovtzer MM (1986) Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Investig 78:1296-1301.
31. Silver J, Russel J, and Sherwood LM (1985) Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cell. Proc Natl Acad Sci USA 82:4270-4273.
32. 3. Arch Biochem Biophys 229:348-354.
33. Tsushima N, Katsumata T, Ishibashi E, Negoro T, and Nakatsuka M (1996) Therapeutic effects of falecalcitriol on secondary hyperparathyroidism and osteodystrophy in 5/6 nephrectomized rats. Kiso to Rinsho 30:2963-2974.